Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with CancerDavid J. Pinato, Javier Marco‐Hernández, Alberto Zambelli et al.|Cancer Discovery|2020Cited by 183
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry studyDavid J. Pinato, David García-Illescas, Josep Tabernero et al.|The Lancet Oncology|2021Cited by 136
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J. Pinato, Enrico Caliman, Daniela Ferrante et al.|The Lancet Oncology|2022Cited by 80
Time-Dependent COVID-19 Mortality in Patients With CancerOnCovid study group, Ariadna Roqué, David J. Pinato et al.|JAMA Oncology|2021Cited by 72
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapyArmando Santoro, Alexia Bertuzzi, Alessandro Comandone et al.|Annals of Oncology|2012Cited by 54